central nervous system neoplasms
Showing 1 - 23 of 23
5-Aminolevulinic Acid Gliolan®: Usage Increase Proposal for
Not yet recruiting
- High Grade Glioma
- +10 more
- 5-Aminolevulinic Acid (5-ALA) Gliolan®
- Fluorescence-Guided Surgery using 5-aminolevulinic acid (5-ALA)
-
Guayaquil, Guayas, EcuadorSociedad de Lucha Contra el Cáncer
Apr 28, 2023
CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)
Not yet recruiting
- Central Nervous System Neoplasms
- +6 more
- B7-H3-CAR T cells
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Apr 18, 2023
Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)
Recruiting
- Breast Neoplasms
- +7 more
-
Canton, OhioGabrail Cancer Center
Jan 24, 2023
CNS Tumors, Medulloblastoma Trial in Worldwide (Pomalidomide)
Active, not recruiting
- Central Nervous System Neoplasms
- Medulloblastoma
-
Stanford, California
- +24 more
Sep 28, 2022
Brain Tumor, Recurrent, Brain Tumor, Pediatric, CNS Tumors Trial in Houston (RRx-001, Temozolomide, Irinotecan)
Recruiting
- Brain Tumor, Recurrent
- +3 more
- RRx-001
- +2 more
-
Houston, TexasTexas Children's Cancer Center
Aug 15, 2022
Neurobehavioral Functioning in Pediatric Brain Tumor Patients
Active, not recruiting
- Brain Tumor
- Central Nervous System Neoplasms
-
Boston, MassachusettsMassachusetts General Hospital
Apr 6, 2022
CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)
Recruiting
- Central Nervous System Neoplasms
- +22 more
-
Bethesda, MarylandNational Institutes of Health
Mar 1, 2022
CNS Tumors, CNS Tumor Trial in Saint Louis (Tc-99m tilmanocept)
Recruiting
- Central Nervous System Neoplasms
- Central Nervous System Tumor
- Tc-99m tilmanocept
-
Saint Louis, MissouriWashington University School of Medicine
Jan 28, 2022
Lymphoma, Non-Hodgkin, CNS Tumors Trial in Trondheim (18F-FDG, 18F-fluciclovine, standard MRI)
Recruiting
- Lymphoma, Non-Hodgkin
- Central Nervous System Neoplasms
- 18F-FDG
- +2 more
-
Trondheim, NorwayNorwegian University of Science and Technology, Department of Ci
Dec 15, 2021
CNS Tumors, Pediatric Cancer, GEN1 Gene Mutation Trial in Brno, Prague (FoundationOneHeme)
Recruiting
- Central Nervous System Neoplasms
- +3 more
- FoundationOneHeme
-
Brno, Czechia
- +1 more
Apr 23, 2021
CNS Tumors Trial (Artificial Intelligence, Practicing Pathologists, Gold Standard)
Not yet recruiting
- Central Nervous System Neoplasms
- Artificial Intelligence
- +2 more
- (no location specified)
Dec 15, 2020
Glioblastoma, Glioblastoma Multiforme, Gliosarcoma Trial run by the NCI (topotecan, pazopanib)
Completed
- Glioblastoma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 3, 2020
Biomarker Analysis of Central Nervous System Tumors
Terminated
- Central Nervous System Neoplasms
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI), 9000 Rockville Pike
Nov 16, 2019
Brain Tumors, CNS Tumors Trial in Houston (TPI287, Bevacizumab)
Terminated
- Brain Neoplasms
- Central Nervous System Neoplasms
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 14, 2019
MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS
Completed
- Central Nervous System Diseases
- Central Nervous System Neoplasms
-
Sarasota, FloridaSarasota Memorial Hospital
Jul 16, 2018
CNS Tumors, Head and Neck Tumors Trial in Philadelphia (EPO906 (epothilone B))
Completed
- Central Nervous System Neoplasms
- Head and Neck Neoplasms
- EPO906 (epothilone B)
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Jul 13, 2018
Brain Cancer, Head Neck Cancer, Cervix Cancer Trial in Philadelphia (Velcade (bortezomib))
Completed
- Brain Cancer
- +3 more
- Velcade (bortezomib)
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
May 5, 2017
Brain Cancer, Arthritis, Rheumatoid, CNS Tumors Trial in Los Angeles, Stanford ([18F]FHBG)
Completed
- Brain Cancer
- +3 more
- [18F]FHBG
-
Los Angeles, California
- +1 more
Mar 12, 2017
Contrast Agents for MRI Perfusion Analysis in Brain Tumor
Terminated
- Central Nervous System Neoplasms
-
Omaha, NebraskaUNMC/Nebraska Medicine
Feb 22, 2017
Retrospective Study of MRI in Pediatric Patients
Completed
- Central Nervous System Disease
- Central Nervous System Neoplasms
- Gadobenate Dimeglumine
- (no location specified)
Jul 18, 2016
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine Positron Emission
Unknown status
- Glioblastoma
- +8 more
-
Munich, Bavaria, GermanyUniversity of Munich, Dep. of Radiation Oncology
Dec 17, 2012
Coproporphyrine Isomers and Methotrexate Elimination
Completed
- Central Nervous System Neoplasms
- +3 more
-
Paris, France
- +1 more
Jul 30, 2012
CNS Tumors, Tumor Metastasis Trial in Boston (Temozolomide)
Terminated
- Central Nervous System Neoplasms
- Neoplasm Metastasis
-
Boston, MassachusettsTufts Medical Center
Apr 26, 2012